A COMPOUND FOR THE TREATMENT OF HEPATITIS C
    13.
    发明公开
    A COMPOUND FOR THE TREATMENT OF HEPATITIS C 有权
    一种治疗丙型肝炎的化合物

    公开(公告)号:EP2768831A1

    公开(公告)日:2014-08-27

    申请号:EP12783457.0

    申请日:2012-10-17

    CPC分类号: C07D487/04

    摘要: The present invention provides (1a
    R ,12b
    S )-8-cyclohexyl-11-fluoro-
    N -((1- methylcyclopropyl)sulfonyl)-1a-((3-methyl-3,8-diazabicyclo[3.2.1]oct-8- yl)carbonyl)-1,1a,2,12b-tetrahydrocyclopropa[
    d ]indolo[2,1-
    a ][2]benzazepine-5- carboxamide (formula I), including pharmaceutically acceptable salts, as well as compositions and methods of using the compound. The compound has activity against hepatitis C virus (HCV) and may be useful in treating those infected with HCV.

    摘要翻译: 本发明提供了(1aR,12bS)-8-环己基-11-氟-N - ((1-甲基环丙基)磺酰基)-1a - ((3-甲基-3,8-二氮杂双环[3.2.1]辛基 -8-基)羰基)-1,1a,2,12b-四氢环丙并[d]吲哚并[2,1-a] [2]苯并氮杂-5-甲酰胺(式I),包括药学上可接受的盐, 和使用该化合物的方法。 该化合物具有抗丙型肝炎病毒(HCV)活性,可用于治疗感染HCV的患者。

    INHIBITORS OF HEPATITIS C VIRUS
    18.
    发明公开
    INHIBITORS OF HEPATITIS C VIRUS 有权
    丙型肝炎病毒的抑制剂

    公开(公告)号:EP2086994A2

    公开(公告)日:2009-08-12

    申请号:EP07863706.3

    申请日:2007-10-31

    CPC分类号: C07K5/0804

    摘要: Macrocyclic peptides are disclosed having the general formula (I) wherein R3, R3', R4, R6, R', X, Q and W are described. Compositions comprising the compounds and methods for using the compounds to inhibit HCV are also disclosed.

    摘要翻译: 公开了具有通式(I)的大环肽,其中描述了R3,R3',R4,R6,R',X,Q和W. 还公开了包含所述化合物的组合物和使用所述化合物抑制HCV的方法。